Literature DB >> 25530118

Plectin-related skin diseases.

Ken Natsuga1.   

Abstract

Plectin has been characterized as a linker protein that is expressed in many cell types and is distinctive in various isoforms in the N-terminus and around the rod domain due to complicated alternative splicing of PLEC, the gene encoding plectin. Plectin deficiency causes autosomal recessive epidermolysis bullosa simplex (EBS) with involvement of the skin and other organs, such as muscle and gastrointestinal tract, depending on the expression pattern of the defective protein. In addition, a point mutation in the rod domain of plectin leads to autosomal dominant EBS, called as EBS-Ogna. Plectin can be targeted by circulating autoantibodies in subepidermal autoimmune blistering diseases. This review summarizes plectin-related skin diseases, from congenital to autoimmune disorders.
Copyright © 2014 Japanese Society for Investigative Dermatology. Published by Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Epidermal basement membrane; Hemidesmosome; Muscular dystrophy; Pyloric atresia

Mesh:

Substances:

Year:  2014        PMID: 25530118     DOI: 10.1016/j.jdermsci.2014.11.005

Source DB:  PubMed          Journal:  J Dermatol Sci        ISSN: 0923-1811            Impact factor:   4.563


  11 in total

1.  The Structure of the Plakin Domain of Plectin Reveals an Extended Rod-like Shape.

Authors:  Esther Ortega; José A Manso; Rubén M Buey; Ana M Carballido; Arturo Carabias; Arnoud Sonnenberg; José M de Pereda
Journal:  J Biol Chem       Date:  2016-07-13       Impact factor: 5.157

2.  Epidermolysis bullosa simplex in sibling Eurasier dogs is caused by a PLEC non-sense variant.

Authors:  Elizabeth A Mauldin; Ping Wang; Thierry Olivry; Paula S Henthorn; Margret L Casal
Journal:  Vet Dermatol       Date:  2016-11-07       Impact factor: 1.589

3.  Identification and Computational Analysis of Novel Pathogenic Variants in Pakistani Families with Diverse Epidermolysis Bullosa Phenotypes.

Authors:  Fehmida F Khan; Naima Khan; Sakina Rehman; Amir Ejaz; Uzma Ali; Muhammad Erfan; Zubair M Ahmed; Muhammad Naeem
Journal:  Biomolecules       Date:  2021-04-22

4.  Plectin Missense Mutation p.Leu319Pro in the Pathogenesis of Autosomal Recessive Epidermolysis Bullosa Simplex.

Authors:  Wei-Ting Tu; Peng-Chieh Chen; Ping-Chen Hou; Hsin-Yu Huang; Jing-Yu Wang; Sheau-Chiou Chao; Julia Yu-Yun Lee; John A McGrath; Ken Natsuga; Chao-Kai Hsu
Journal:  Acta Derm Venereol       Date:  2020-08-18       Impact factor: 3.875

5.  A novel PLEC nonsense homozygous mutation (c.7159G > T; p.Glu2387*) causes epidermolysis bullosa simplex with muscular dystrophy and diffuse alopecia: a case report.

Authors:  Zoe Argyropoulou; Lu Liu; Linda Ozoemena; Claudia C Branco; Raquel Senra; Ângela Reis-Rego; Luisa Mota-Vieira
Journal:  BMC Dermatol       Date:  2018-01-20

Review 6.  Keratins as an Inflammation Trigger Point in Epidermolysis Bullosa Simplex.

Authors:  Nadezhda A Evtushenko; Arkadii K Beilin; Anastasiya V Kosykh; Ekaterina A Vorotelyak; Nadya G Gurskaya
Journal:  Int J Mol Sci       Date:  2021-11-18       Impact factor: 5.923

Review 7.  Plectin in Skin Fragility Disorders.

Authors:  Dimitra Kiritsi; Leonidas Tsakiris; Franziska Schauer
Journal:  Cells       Date:  2021-10-14       Impact factor: 6.600

8.  Quantitative Proteomics Analysis Expands the Roles of Lysine β-Hydroxybutyrylation Pathway in Response to Environmental β-Hydroxybutyrate.

Authors:  Wanting Hou; Guobin Liu; Xuelian Ren; Xianming Liu; Lei He; He Huang
Journal:  Oxid Med Cell Longev       Date:  2022-02-24       Impact factor: 6.543

9.  Epidermolysis Bullosa With Congenital Absence of Skin: Congenital Corneal Cloudiness and Esophagogastric Obstruction Including Extended Genotypic Spectrum of PLEC, LAMC2, ITGB4 and COL7A1.

Authors:  Pharuhad Pongmee; Sanchawan Wittayakornrerk; Ramrada Lekwuttikarn; Sasikarn Pakdeeto; Piangor Watcharakuldilok; Chatchay Prempunpong; Thipwimol Tim-Aroon; Chawintee Puttanapitak; Piyawan Wattanasoontornsakul; Thitiporn Junhasavasdikul; Parith Wongkittichote; Saisuda Noojarern; Duangrurdee Wattanasirichaigoon
Journal:  Front Genet       Date:  2022-04-01       Impact factor: 4.772

Review 10.  Microtubule-Actin Crosslinking Factor 1 and Plakins as Therapeutic Drug Targets.

Authors:  Quincy A Quick
Journal:  Int J Mol Sci       Date:  2018-01-26       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.